low molecular weight heparin overdose: a 10 year case series
Authors
abstract
background: low molecular weight heparin (lmwh) is used for the treatment and prevention of coagulative disorders. few patients receiving therapeutic doses of lmwh develop major hemorrhage. currently there are few reports in the literature on acute overdose on adults. in this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. methods: a retrospective chart review of california poison control system (cpcs) database: visual dot lab during 1997 to 2007 was obtained. all patients with a definite reported overdose of subcutaneous injection of lmwh were included. results: in total, 21 patients who were all exposed to enoxaparin were studied. the reasons for overdose included medical miscalculation (3 cases, all infants), intentional misuse (2 patients), accidental overdose (7 cases), suicidal attempt (7 cases) and unknown in 2 patients. 7 cases were documented to have overdosed more than 2 times the therapeutic dose. the overdose ranged from 50 mg to 1300mg (0.1-80 times the therapeutic range). no patients were documented to experience bleeding or have thrombocytopenia although complete follow-up was only available for 11 patients. reassurance was given to patients with less than 0.14 times the therapeutic dose. the 2 patients who received protamine were overdosed with more than 2.5 times the therapeutic dose of enoxaparin. conclusion: most patients had no complications and were not treated with protamine. this study suggests that a large dosage of lmwh is unlikely to result in any life threatening complications, though further studies are needed to certainly conclude about this. the use of protamine in lmwh overdose seems to remain controversial.
similar resources
Low Molecular Weight Heparin Overdose: A 10 Year Case Series
Background: Low molecular weight heparin (LMWH) is used for the treatment and prevention of coagulative disorders. Few patients receiving therapeutic doses of LMWH develop major hemorrhage. Currently there are few reports in the literature on acute overdose on adults. In this study, clinical profile, treatment and outcome of 21 patients who acutely overdosed enoxaparin are described. Method...
full textIntentional low-molecular-weight heparin overdose: a case report and review.
The reversal of low-molecular-weight heparins, particularly at supratherapeutic levels, remains challenging. The paucity of literature available to guide the treatment of these patients makes their management difficult for primary care providers, surgeons, and subspecialists alike. We report the case of a 34-year-old woman, who intentionally overdosed on enoxaparin (Lovenox) in a suicide attemp...
full textLow Molecular Weight Heparin-Induced Skin Necrosis: A Case Report
Low molecular weight heparins (LMWHs) are the standard agents used for antithrombotic therapy and prophylaxis. Despite their widespread use, reports about adverse effects from LMWHs are very scarce. Heparin-induced skin necrosis at the injection site is a rare adverse effect, more commonly associated with unfractionated heparin (UFH) rather than with LMWH, while its mechanism remains unclear. T...
full textHeparin and low-molecular-weight heparin.
Heparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration. They have been shown to be at least as effective and safe as unfractionated heparin and have repl...
full textPerioperative Low - Molecular - Weight Heparin
In previous randomised clinical trials of thromboprophylaxis after total hip replacement, low-molecular-weight heparin has been given for an arbitrary 7 to 14 days. The risk factors are mainly perioperative and it is possible that a shorter course may be adequate. We assessed the safety and effectiveness of a three-day course. We assessed 156 primary THR patients after randomisation to either a...
full textMy Resources
Save resource for easier access later
Journal title:
asia pacific journal of medical toxicologyجلد ۲، شماره ۲، صفحات ۶۸-۷۰
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023